
- 1982
- 1985
- 1986
- 1986
- 1990
- 1993
- 1994
- 1996
- 1996
- 2001
- 2001
- 2012
- 2013
- 2013
- 2013
- 2014
- 2014
- 2016
- 2018
- 2019
- 2020
Incorporation
Company was incorporated
CEO joins the journey
Mr Vivek Dhawan our current CEO joined the Company
manufacturing-facility
Received approval from Thai FDA for Samut Prakarn Facility in Thailand and established manufacturing facility with 2 lines and a capacity of 230 million soft gel capsules
First OEM Customer
Began manufacturing Nifedipine for a third party OEM client.
Mega Products – Incorporated
Established Mega Products Limited now renamed as Mega Lifesciences PTY Limited to market and sell medicinal supplements under own brands.
Branded business
Commenced Branded Products business
Medicraft Story
Acquired Medicraft range of Brands
Regional Presence
Expanded to Vietnam, Myanmar and Cambodia for Brands business and Distribution business
Australia facility
Established manufacturing plant in Australia
German GMP certification
Obtained GMP certification from the German Health Authority, the district of Arnsberg for manufacturing of soft gel products
Mega We Care
Registered Mega We care brand name
Acquisition in Vietnam
Acquisition of global rights of Eugica brand
Australia Expansion
Australia manufacturing facility expanded
Listing of Shares
Listing of shares on the Stock Exchange of Thailand and marked November 19, 2013 as the first day of trading.
Thailand facility upgrade
Thailand manufacturing facility upgrade.
Africa Focus
Company kicked off Africa Focus
Share warrants
Long term performance rewards announced in the form of Stock Options
Biolife Acquisition in Malaysia
Acquired Bio-life Marketing SDN. BHD., a Malaysian Company engaged in the business of marketing medicinal supplements and healthcare products including probiotics, essential fatty acids, herbal products, nutritional and skin care.
Generic Products acquired from Sandoz
Acquisition of Generic Products portfolio from Sandoz Gmbh in Myanmar and Ethiopia
Facility in Indonesia
Acquisition of 83.33% shares of PT Futamed Pharmaceuticals, Indonesia, a company engaged in manufacturing and marketing pharmaceuticals and medicinal supplements in Indonesia.
Present
Now present in 35 countries and with more than 4,700 employees

- 2019
- 2018
- 2017
- 2016
- 2014
Moving To Solar Power
Completed installation of a 957 KWp Solar Power plant at our Thailand warehouse to avoid 1,000 tons of our annual carbon footprint. Additionally, 40 percent of products manufactured at plant-2 are produced with clean energy.
Plastic Waste Reduction
We reduced our overall waste by achieving our overall equipment effectiveness (OEE) target in our Thailand facility packing lines. In addition, a $1 million investment was approved for a new 957KWp Solar rooftop. Our Myanmar offices replaced plastic water bottles for guests, meetings, and training rooms with glass jars, as…
Giving Back To Nature
A new clean warehouse design was approved at our Bangpu facility in Thailand, alongside the launch of a ‘Focussed Efficiency Improvement Program’. As part of a global effort to fight climate change, Mega Lifesciences Ltd Myanmar and the Myanmar Forestry Department, in cooperation with the team of Vitacap, planted trees…
Improved Energy Efficiency
Plant -1 and Zone-2 of Plant-2 in Thailand achieved better energy efficiency with 100 percent LED bulb lighting. Our MEGA Bangpu Plant Received the Level-3 Green Industry Award. Meanwhile, senior Managers of Mega Myanmar planted saplings at Kalaw, the Town of Pines.
Optimizing Resource Usage
We implemented multiple sustainability initiatives in our manufacturing facilities, such as building a new underground waste water treatment plant, converting to natural gas boilers, energy-saving T5 lighting and non-CFC air conditioning, and solar panels for outdoor lighting. Our new Australian plant was also designed with environmental considerations in mind, with…